Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development Astera Labs Inc ALAB Q1 2026 Earnings EPS Surpasses Estimates as Shares Climb TRIB Q4 2024 Earnings Significant EPS Miss with 27255 Surprise Revenue Not Disclosed CATY Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction KOSS Q1 2026 Earnings Negative EPS as Company Faces Continued Headwinds